FDA Weighs Stronger Warning on Antidepressants

Scientific advisers to the Food and Drug Administration meeting in Washington, D.C. agree that there is a link between antidepressants and an increased risk of suicidal behavior among some children. FDA staff told the panel members that a new warning added in March to antidepressants called SSRIs appeared to have little impact on children's use of the drugs. The panel is expected to vote on whether stronger warning labels or other restrictions are needed on the drugs. Hear NPR's Melissa Block and NPR's Joanne Silberner.

Copyright © 2004 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

Copyright © 2004 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.